Podcasts
ToxChats©

ToxChats©

ACT ToxChats 52 - Weight of Evidence Approach to Carcinogenicity: An Interview with Todd Bourcier and Tim McGovern

The American College of Toxicology podcast program, ToxChats ©, reports on cutting-edge news in toxicological research from around the globe.

Geen beschrijving van de aflevering beschikbaar.

Gepubliceerd 31 jul. 2026

Afleveringen

31 jul. 2026

27 feb. 2026

07 nov. 2025

15 okt. 2025

30 sep. 2025

17 jul. 2025

07 jul. 2025

23 jun. 2025

01 apr. 2025

03 feb. 2025

18 dec. 2024

04 nov. 2024

02 sep. 2024

16 aug. 2024

01 jul. 2024

04 mrt. 2024

29 jan. 2024

22 jan. 2024

15 jan. 2024

08 jan. 2024

28 nov. 2023

05 sep. 2023

05 jul. 2023

28 apr. 2023

03 mrt. 2023

06 jan. 2023

03 nov. 2022

08 sep. 2022

16 jun. 2022

24 mrt. 2022

20 jan. 2022

17 jun. 2021

04 mrt. 2021

06 jan. 2021

05 nov. 2020

20 aug. 2020

27 apr. 2020

10 apr. 2020

10 feb. 2020

03 okt. 2019

16 aug. 2019

30 nov. 2018

19 jul. 2018

26 apr. 2018

27 sep. 2017

Meer Wetenschap-podcasts

Internationale Wetenschap-podcasts

ToxChats©

Afleveringen

Weight of Evidence Approach to Carcinogenicity: An Interview with Todd Bourcier and Tim McGovern

Next-Gen Toxicology: Inside the Organ Chip Revolution with Dr. Donald Ingber

Transitioning from Industry to Consulting, Independent vs. Firm Consultant

Human and Environmental Health Topic: Next Generation Risk Assessment

The Science of Mentorship: A Conversation with Richard DiMarchi

From RIF to Reboot: A Guide for Early to Mid-Career Toxicologists

Discussing the FDA's Announcement to Phase Out Animal Testing in Monoclonal Antibody Development

Specialty Tox Topic: In Vivo Dermal Drug Development

Specialty Tox Topic: In Vitro Dermal Drug Development

Occupational Toxicology and Product Quality: Navigating Impurities and Occupational Safety

The Past, Present, and Future of Safety Pharmacology

Career Path: Toxicologist in the Food Industry

Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study

Career Path: Pharmaceutical Consultant in the Field of Toxicology

3D Printing Emissions and Potential Health Effects from a Consumer Perspective

Career Path: Pharmaceutical Consultant in the Field of Occupational, Environmental, and Quality Toxicology

Discussions on Identifying Seizures Liability in Nonclinical Studies

Alternative and Nontraditional Species Series: The Use of Transgenic and Disease Mouse Animal Models for Toxicology Studies

Identifying an Appropriate Sponsor to Support Your Growth and Success in the Workplace

Alternative and Nontraditional Species Series: Fertilized Egg Model as an Alternative Species for Safety Assessment Studies

Alternative and Nontraditional Species Series: Advantages and Challenges of Using Rabbits

Alternative and Nontraditional Species Series: Sheep as an Alternative Model for the Safety Evaluation of Medical Devices

Alternative and Nontraditional Species Series: Mini Pig–Alternatives to Traditional Nonrodent Models in Nonclinical Safety Testing

Medical Devices: Safety Evaluation and Becoming a Medical Device Toxicologist

Interviewing and Negotiation 101 for Toxicologist Roles in the Biopharmaceutical Industry

The History and Future of Oligonucleotide Drug Development

The Opioid Crisis: Misconceptions, History, and Interventions

Covid-19 Part 2: New Type of Antibody-Dependent Enhancement Associated with SARS-CoV-2 Virus: MIS-C, MIS-A, and MIS-N

Covid-19 Part 1: Antibody-dependent Enhancement of Disease

Artificial Intelligence (AI) Use in Toxicology

Overview of mRNA Vaccines

Tips for Taking the ABT Exam

Moving from Minion to Manager

Off the Beaten Path: The Nonclinical Development of Gene Therapy Products to Cure Monogenic Diseases

Digital Pathology

Expedited FDA Programs

Toxicology Salary Survey

Pediatric Drug Development

CAR/T: New Modalities Paving the Way for Cancer

History and Risk Assessment of Vaccines—Q&A

Scientific Communication: Distilling and Rehearsing to Reach Your Audience

AI and Big Data for Safety Testing

Shining a Light on the Science and Strategy of Phototoxicity Assessments

The Twists and Turns of GI Health and Medicine: An Interview with Dr. Alessio Fasano

The Scientific Approach to Address Uncommon Routes and Best Practices for Forming a Working Group

CRISPR Then and Now: An Interview with Dr. Jacob Corn, ACT 2015 Plenary Speaker

In Vitro and Alternative Models for Regulatory Submission

Regulation of E-Cigarettes

The Opioid Epidemic

Biomarkers